CMPS compared with TARS: revenue, margins and what each company keeps, and the suppliers and customers both name

CMPSCOMPASS Pathways plc

Mkt capRevenueRevenue

TARSTarsus Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

CMPSCOMPASS Pathways plc

TARSTarsus Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CMPS

No earnings history for CMPS.

TARS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.5%▲+6.59%×0.63

Q1 FY26±13.4%▼−1.24%×0.09

Feb 24 '26±14.8%▲+7.79%×0.53

Nov 5 '25±13.3%▼−4.62%×0.35

= impliedCMPS realized, solidTARS realized, hatchedOne scale, both sides: full bar = 15%× = |realized| ÷ impliedSource: market data

CMPSCOMPASS Pathways plc

8.41▼−27.28%· post 8.74

Mkt cap$1.6BRevenue—Revenue—

TARSTarsus Pharmaceuticals, Inc.

73.36▼−1.99%· post 73.37

ClosedNov 2 '26

Mkt cap$3.3BRevenue$174MQ2 FY26Revenue$451MFY25

Compare

ClosedNov 2 '26

CMPSCOMPASS Pathways plc

TARSTarsus Pharmaceuticals, Inc.

8.41▼−27.28%post 8.74

Price

73.36▼−1.99%post 73.37

$1.6B

Mkt cap

$3.3B

—

Revenue

$174MQ2 FY26

—

Revenue

$451MFY25

CMPS8.41▼−27.28%vsTARS73.36▼−1.99%ClosedNov 2 '26